Orbimed Advisors - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,755,000
-91.2%
58,000
-93.3%
0.04%
-92.6%
Q4 2018$31,483,000
-58.1%
872,100
-28.5%
0.58%
-35.6%
Q3 2018$75,081,000
-41.0%
1,219,830
-35.3%
0.90%
-40.4%
Q2 2018$127,271,000
+24.5%
1,884,1000.0%1.52%
+19.8%
Q1 2018$102,212,000
+28.7%
1,884,100
+41.7%
1.27%
+26.1%
Q4 2017$79,444,000
+13.7%
1,329,600
-7.5%
1.00%
+50.4%
Q3 2017$69,896,000
-27.4%
1,438,182
-21.5%
0.67%
-33.8%
Q2 2017$96,253,000
+41.9%
1,831,647
+22.4%
1.01%
+31.2%
Q1 2017$67,844,000
+19.8%
1,496,0000.0%0.77%
+6.5%
Q4 2016$56,624,000
+88.2%
1,496,000
+87.7%
0.72%
+110.5%
Q3 2016$30,083,000797,1000.34%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders